|
|
Remember, when investing your capital is at risk. |
|
|
|
|
|
As you have previously expressed your interest in Occuity, our products and mission, we wanted to let you know, we’re shortly launching the crowdfunding element of our current investment round. We're delighted to be able to give you the opportunity to beat the rush and get priority access before we go live to the public on Seedrs. You have a limited time to pre-register. |
|
|
|
|
|
|
|
|
|
|
|
By investing, you will become an equity shareholder in Occuity. Your investment will support us bringing our
highly disruptive, non-contacting screening, monitoring and ophthalmic products to market including, of course, our non-invasive glucose meter, The Occuity Indigo.
You'll know better than most that Occuity's technology has the potential to improve the lives of hundreds of millions of people. That is our mission! |
|
Revolutionary multi-patented optical handheld technology will deliver safe, instant and contact-free disease screening & monitoring.
|
|
Addressing combined global markets worth over $39Bn/year. Ophthalmology - $5Bn, Diabetes Screening - $20Bn & Diabetes Monitoring - $14Bn.
|
|
Commercial negotiations with leading lens&spectacle manufacturers and European distributor network being established.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- Why is we crowdfunding?
- What are the risks?
- Can I invest a small amount?
- What is the minimum investment?
- Is this an EIS Approved Investment?
|
|
- What will my money be used for?
- Who can buy Occuity Shares?
- Can I sell my shares?
- What is the Seedrs secondary Market?
- Are Seedrs investments safe?
|
|
|
|
|
|
This email has been approved as a financial promotion by Seedrs Limited.
Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. Tax treatment depends on individual circumstances and is subject to change in future. Seedrs does not make investment recommendations to you and any investment decision should be made on the basis of the full campaign. No communications from Seedrs, through email or any other medium, should be construed as an investment recommendation.
Seedrs Limited is authorised and regulated by the Financial Conduct Authority. Seedrs Limited is a limited company, registered in England and Wales (No. 06848016), with registered office at Churchill House, 142-146 Old Street, London EC1V 9BW
| |
|
|
|
|
|
Don't forget to join the conversation
Thanks for joining our community. Make sure you follow us on social media and invite your friends and family to! |
|
|
|
|
|
Our mailing address is: Occuity Ltd
Authorized representative: Dan Daly
Address: marketing@occuity.com
Phone: 01183 500 800
Address: Occuity Ltd, 5th Floor, The Blade Abbey Square Reading, UK RG1 3BE
Company Registration Number: 12192959
|
|
|
|
.png "https://www.seedrs.com/occuity2022/coming-soon")
